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Vitamin D levels in an Australian and New
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pregnancy outcome
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Abstract
Background: Pregnant women are at increased susceptibility to vitamin D deficiency. Hence, there is continuing
interest in determining how vitamin D influences pregnancy health. We aimed to compare vitamin D status in two
distinct populations of pregnant women in Australia and New Zealand and to investigate the relationship between
vitamin D status and pregnancy outcome. This included evaluating possible effect measure modifications according
to fetal sex.
Methods: Serum 25-hydroxy vitamin D (25(OH)D) was measured at 15 ± 1 weeks’ gestation in 2800 women from
Adelaide and Auckland who participated in the multi-centre, prospective cohort SCreening fOr Pregnancy
Endpoints (SCOPE) study.
Results: Mean serum 25(OH)D in all women was 68.1 ± 27.1 nmol/L and 28% (n = 772) were considered vitamin D
deficient (< 50 nmol/L). Serum 25(OH)D was lower in the women recruited in Adelaide when compared to the
women recruited in Auckland and remained lower after adjusting for covariates including maternal body mass
index and socioeconomic index (Adelaide: 58.4 ± 50.3 vs. Auckland: 70.2 ± 54.5 nmol/L, P < 0.001). A 53% decreased
risk for gestational diabetes mellitus (GDM) was observed with high (> 81 nmol/L) “standardised” vitamin D status
when compared to moderate-high (63–81 nmol/L, aRR, 0.47; 95% CI: 0.23, 0.96). Marginal sex-specific differences
occurred between vitamin D status and GDM: women carrying a female fetus had a 56% decreased risk for GDM
in those with low-moderate levels of standardised vitamin D (44–63 nmol/L) compared to moderate-high levels
(aRR: 0.44; 95% CI: 0.20, 0.97), whilst in women carrying a male fetus, a 55% decreased risk of GDM was found
with high standardised vitamin D when compared to moderately-high vitamin D, but this was not statistically
significant (aRR: 0.45; 95% CI: 0.15, 1.38).
Conclusions: High serum 25(OH)D at 15 ± 1 weeks’ gestation was shown to be protective against the
development of GDM. A possible association between fetal sex, vitamin D status and GDM provides further
questions and encourages continual research and discussion into the role of vitamin D in pregnancy, particularly
in vitamin D replete populations.
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Background
With an increasing prevalence of vitamin D deficiency
and insufficiency reported both in Australia and New Zea-
land, as well as worldwide [1], there is continuing interest
in determining how vitamin D deficiency may influence
health in pregnancy. Evidence suggests that vitamin D de-
ficiency is associated with a number of pregnancy compli-
cations including preeclampsia (PE), gestational diabetes
mellitus (GDM) and spontaneous preterm birth (sPTB)
[2–4]. However, inconsistencies between studies reflect
uncertainty about the true effect of vitamin D deficiency
on pregnancy outcome [5, 6]. This may be explained, in
part, by inadequate control of related risk factors and con-
founders in statistical analyses, variations between assays
that measure vitamin D and significant heterogeneity be-
tween studied populations [6].
Vitamin D status is determined by measuring circulating
serum levels of 25-hydroxy vitamin D2+ 3 (25(OH)D). In
Australia and New Zealand, the deficiency cut-offs are
based on the role of vitamin D in bone health where serum
25(OH)D ≥ 50 nmol/L at the end of winter is required for
optimal musculoskeletal health [1]. Furthermore, it has
been established that serum 25(OH)D ≥ 50 nmol/L is rec-
ommended during pregnancy and lactation [7]. The inci-
dence of vitamin D deficiency (˂50 nmol/L) is frequent
among pregnant women even in areas such as Australia
and the North Island of New Zealand where sunlight ex-
posure is high. Studies focused on high-risk populations,
for example, veiled, dark-skinned or obese women in
Australia and New Zealand, report between 50 and 94% of
women to be vitamin D deficient [8–10]. Reports from
lower-risk groups have indicated that vitamin D deficiency
occurs in 25–55% of pregnant women [11–13].
There are numerous studies which have shown that
vitamin D deficiency is associated with adverse preg-
nancy outcomes (Most recent: [14–17]), particularly in
populations that reside at higher latitudes. However,
studies in women from Australia and New Zealand are
less consistent. Previous studies on pregnant Australian
and New Zealand women have reported that while cir-
culating 25(OH)D was significantly lower in women with
PE, sPTB, GDM and those who delivered a small-for
gestational age (SGA) infant, no association between
vitamin D deficiency and these pregnancy complications
was found after adjusting for covariates [18–20]. Differ-
ences in ethnicity [21], solar exposure and geographical
location, as well as genetics [22] and supplementation
[23–25], are known to affect 25(OH)D status and there-
fore influence study outcomes. Furthermore, the gesta-
tion at which vitamin D was measured is also important.
In the case of preterm delivery, vitamin D status mea-
sured closer to the delivery date was more significantly
associated with preterm delivery than earlier measures
[26]. However, measuring circulating 25(OH)D in early
pregnancy is common and potentially clinically useful as
this is prior to when many of the pregnancy complica-
tions that affect late gestation manifest.
Using a robust, validated chemiluminescent-based assay
to measure serum 25(OH)D [27], we aimed to investigate
the differences between vitamin D status in early preg-
nancy in two distinct populations of nulliparous women
from Australia and New Zealand. We also aimed to exam-
ine the relationship between serum 25(OH)D at 15 ±
1 weeks’ gestation and the risk of an adverse pregnancy
outcome and included determining the effect modification
of fetal sex on the association between maternal vitamin
D status and pregnancy outcome.
Methods
Study population
This study utilised data collected from the multi-centre,
prospective cohort Screening for Pregnancy Endpoints
(SCOPE) study [28]. Nulliparous women carrying a
singleton pregnancy were recruited between November
2004 and September 2008 in Adelaide (Australia) and
Auckland (New Zealand). Ethics approval was obtained
from Central Northern Adelaide Health Service Ethics
of Human Research Committee on 2 September 2005
(ethics number REC 1714/5/2008) and Northern Region
Ethics Committee, in Auckland on 23 April 2003 (ethics
number AKX/02/00/364). All participants provided writ-
ten informed consent. At 15 ± 1 weeks’ gestation, women
were interviewed by a research midwife and asked ques-
tions on maternal demographics and lifestyle and had
physical measurements taken, including height and
weight. Records included ethnicity, age, body mass index
(BMI), socioeconomic index (SEI) and multivitamin use
[29]. BMI was calculated as weight (kg)/height2 (m2).
Obesity was defined as BMI ≥30 kg/m2, overweight as
BMI ≥25 and < 30 kg/m2, normal weight as BMI > 20
and < 25 kg/m2 and underweight as BMI ≤20 kg/m2. SEI
was calculated using the New Zealand SEI of occupa-
tional status, deriving a number between 10 and 90
based on the woman’s occupation; a higher number indi-
cates higher socioeconomic status [30]. This population
of women was predominantly Caucasian and thus mater-
nal ethnicity was categorised into 2 main groups; Cauca-
sian and non-Caucasian. Uncomplicated pregnancies were
defined as those without any pregnancy disorder who de-
livered an appropriate weight for gestational age infant at
term (≥37 weeks gestation) [31]. Pregnancy complications
studied included PE, gestational hypertension (GH),
GDM, sPTB and SGA and have been previously defined
[28, 29, 31, 32].
Measurement of serum 25(OH)D
Non-fasting whole peripheral blood samples were collected
into non-heparinised tubes at 15±1 weeks’ gestation. Serum
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was processed within 4 h of collection and stored at − 80 °
C until required. Unlike the previously published data on
vitamin D in the Auckland cohort [20], serum 25(OH)D
was measured using the IDS-iSYS chemiluminescent-based
assay (Abacus, ALS) as per the manufacturer’s instructions.
Average intra- and inter-assay coefficient of variation (CV)
were 5.4 and 8.8%, respectively. Both serum 25(OH)D3 and
25(OH)D2 were measured independently and combined to
provide a total 25(OH)D in nmol/L [27].
Statistical analyses
Statistical analyses were performed in R (v3.1.1) [33].
Data were checked for normality using a Shapiro-Wilks
test and differences between women recruited in Adel-
aide compared to Auckland were tabulated and com-
pared using a Welch’s t-test (continuous variables) or
Fisher’s exact test (categorical variables).
Given that the month in which the serum was sampled
heavily influences vitamin D status, “standardised” serum
25(OH)D concentrations were calculated as previously
described [34] in order to normalise against seasonal
variation. Briefly, vitamin D concentrations were stan-
dardized by taking the difference of 25(OH)D concentra-
tion to the average 25(OH)D concentration of the
corresponding month. This 25(OH)D concentration was
then added to the overall population mean 25(OH)D
concentration: 68.09 nmol/L. Quartiles, based on the
distribution amongst the population of women studied,
in the standardised concentrations were then used to
create cut-points and designated ‘low’ (< 44 nmol/L),
‘low-moderate’ (44–63 nmol/L), ‘moderate-high’ (63–
81 nmol/L) and ‘high’ (> 81 nmol/L) categories of serum
25(OH)D.
Generalised linear models (Poisson with log link and ro-
bust variance estimates) were used to calculate the risk ra-
tios for pregnancy complications by standardised serum
25(OH)D concentrations calculated among the women
who had an uncomplicated pregnancy. Potential con-
founders for vitamin D status were assessed using linear
modelling. Maternal age, BMI, SEI, alcohol consumption
at 15 ± 1 weeks’ gestation (never/former vs. current), rec-
reational walking (1–3 times/week and ≥ 4 times/week vs.
never), ethnicity (Caucasian vs. non-Caucasian) and re-
cruitment site (Adelaide vs. Auckland) were significantly
associated with serum 25(OH)D and along with smoking
status at 15 ± 1 weeks’ gestation (never/former vs. current)
included as main effects within the generalised linear
models. These analyses were also repeated but using the
current definitions of vitamin D deficiency: < 25, 25–50,
50–75 and > 75 nmol/L in the non-standardised data [7].
We also stratified based on fetal sex to evaluate possible
effect measure modifications according to whether the
mother was carry a male or female fetus.
Results
Population characteristics
Of 3229 women recruited as part of SCOPE at the Adel-
aide and Auckland centres, serum samples at 15 ±
1 weeks’ gestation to measure 25(OH)D were available
for 2800 (87%) women of whom, 1156 (41%) were re-
cruited in Adelaide and 1644 (59%) were recruited in
Auckland. Maternal characteristics are shown in Table 1.
Compared to women who were recruited at the Adelaide
site, women recruited in Auckland were older, had a
lower BMI, less likely to smoke or drink alcohol during
pregnancy and more likely to eat fruit and undertake
recreational walks. Mean ± SD SEI of the Auckland
women was also higher compared to that in women re-
cruited in Adelaide (Auckland: 48.0 ± 14.8 vs. Adelaide:
27.7 ± 10.5, P < 0.001). Given that all these factors signifi-
cantly influenced serum 25(OH)D in the linear regres-
sion model, it was unsurprising that vitamin D status of
the women was significantly different between the two
recruitment sites. However, after adjusting for maternal
age, BMI, SEI, smoking status and alcohol consumption
at 15 ± 1 weeks’ gestation, ethnicity, recreational walking
and season, the women recruited in Adelaide still had
significantly lower serum 25(OH)D when compared with
those in Auckland (Adelaide: 58.4 ± 50.3 vs. Auckland:
70.2 ± 54.5 nmol/L, P < 0.001) indicating the influence of
other confounders not measured as part of the study on
vitamin D status.
Standardising serum 25(OH)D based on seasonal
variation
As expected, there was a seasonal influence on serum
25(OH)D and thus, “standardised” vitamin D concentra-
tions were calculated to account for the month of serum
collection. Average hours of sunlight per day in Adelaide
from September 2005 to September 2008 were obtained
from the Australian Government Bureau of Meteorology
and compared against serum vitamin D measured in the
women recruited in Adelaide (Fig. 1a; black line/left axis
serum 25(OH)D and grey line/right axis average hours
of sunlight). The means for serum 25(OH)D by month
of sampling were also separated for women recruited in
Adelaide and women recruited in Auckland (Fig. 1b).
Serum 25(OH)D and pregnancy outcome
Of the 2800 women present in this study, 1217 (43%)
women went on to develop a pregnancy complication and
included 5.8% (n = 161) who developed PE, 7.6% (n = 213)
who developed GH, 3.3% (n = 92) who developed GDM,
5% (n = 139) who spontaneously delivered preterm and
10.6% (n = 298) who delivered an SGA infant.
The association between “standardised” 25(OH)D with
pregnancy complications is presented in Table 2. Using
moderate-high as a reference (standardised vitamin D
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63–81 nmol/L), there was no appreciable effect of hav-
ing a low, low-moderate or high vitamin D with the risk
of developing any pregnancy complication after adjust-
ing for confounders. However, when each pregnancy
complication was analysed separately, a 53% decreased
risk for GDM was observed with high vitamin D status
when compared to moderate-high status (aRR: 0.47; 95%
CI: 0.23, 0.96). When women were categorised based on
clinical definitions of vitamin D deficiency and serum
25(OH)D between 50 and 75 nmol/L used as the refer-
ence, no significant relationship between vitamin D sta-
tus and adverse pregnancy outcome was found (Table 2).
Although, the point estimates indicated a marginal in-
creased risk for developing any pregnancy complication
Table 1 Participant characteristics and comparison of characteristics between women recruited at the Adelaide and Auckland
SCOPE centres
All women (n = 2800) Adelaide (n = 1156) Auckland (n = 1644) P value*
Age yrs, mean (SD) 28 (6) 23.73 (5.11) 30.44 (4.82) <0.0001
BMI kg/m2, mean (SD) 25.8 (5.44) 27.04 (6.56) 24.88 (4.26) <0.0001
Ethnicity <0.0001
Caucasian 2449 (87) 1060 (92) 1389 (84)
Non Caucasian 351 (13) 96 (8) 255 (16)
Smoking status, n (%) <0.0001
No 2152 (77) 704 (61) 1448 (88)
Quit during pregnancy 306 (11) 175 (15) 131 (8)
Smoking 342 (12) 277 (24) 65 (4)
Alcohol Consumption, n (%) <0.0001
No 1480 (53) 708 (61) 772 (47)
Stopped during pregnancy 1185 (42) 397 (34) 788 (48)
Consuming alcohol 135 (5) 51 (4) 84 (5)
Fruit Intake, n (%) <0.0001
≥1x per day 2032 (73) 586 (51) 1446 (88)
3-6x per week 405 (14) 272 (24) 133 (8)
1-2x per week 223 (8) 181 (16) 42 (3)
1-3x per month or less 140 (5) 117 (10) 23 (1)
Recreational Walking <0.0001
Never 428 (15) 265 (23) 163 (10)
1-3 times/week 1773 (63) 668 (58) 1105 (68)
≥4 times/week 590 (22) 221 (19) 369 (23)
Time watching TV <0.0001
<5 hours per day 2404 (86) 901 (78) 1503 (92)
≥5 hours per day 387 (14) 253 (22) 134 (8)
Season serum was sampled 0.3213
Summer 636 (23) 278 (24) 358 (22)
Autumn 705 (25) 273 (24) 432 (26)
Winter 727 (26) 300 (26) 427 (26)
Spring 732 (26) 305 (26) 427 (26)
Serum 25(OH)D nmol/L, mean (SD) 68.09 (27.14) 60.06 (23.68) 73.74 (27.99) <0.0001
Vitamin D Status <0.0001
<25 nmol/L 99 (4) 48 (4) 51 (3)
25-50 nmol/L 673 (24) 375 (32) 298 (18)
50-75 nmol/L 928 (33) 422 (37) 506 (31)
>75 nmol/L 1098 (39) 311 (27) 787 (48)
*P values for continuous variables were determined using a Welch’s t-test and categorical variables a Fisher’s exact test comparing Adelaide and Auckland women
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with severe (< 25 nmol/L) vitamin D deficiency com-
pared to those who had levels between 50 and 75 nmol/
L (aRR: 1.10; 95% CI: 0.89, 1.36).
Serum 25(OH)D, pregnancy outcome and fetal sex
As there is evidence to suggest that vitamin D metabol-
ism within the placenta may differ with respect to fetal
sex [35] thus, we assessed the effect of “standardised”
vitamin D status on pregnancy outcome stratified by
fetal sex (Table 3). Although not statistically significant,
point estimates for women carrying a male fetus indicated
decreased risk of having any pregnancy complication with
high serum 25(OH)D compared to moderately-high (aRR:
0.86; 9%% CI: 0.71, 1.04). This was largely driven by a 55%
decreased risk of GDM in women with a male fetus with
high standardised serum 25(OH)D when compared to
those carrying a male fetus with moderate-high serum
25(OH)D (aRR: 0.45; 95% CI: 0.15, 1.38). Conversely, if a
woman was carrying a female fetus, there was generally
no effect of having low, low-moderate or high standar-
dised serum 25(OH)D on developing any pregnancy com-
plication compared to moderate-high levels (Table 3).
Although, a 56% decreased risk for GDM was ob-
served in those with low-moderate levels of standar-
dised vitamin D when compared to moderate-high
levels for women carrying a female fetus (aRR: 0.44;
95% CI: 0.20, 0.97). Similar results were observed
when vitamin D status was based on clinical defini-
tions of deficiency (Additional file 1: Table S1).
Discussion
This study adds to the current body of literature on vita-
min D status in a population of pregnant Australian and
New Zealand women and provides insight into normal
circulating levels of 25(OH)D in early pregnancy. It is
the largest prospective cohort study to assess vitamin D
status within the international SCOPE cohort, compar-
ing and combining two distinct populations of pregnant
women living at similar latitude and provides a greater
understanding of vitamin D deficiency and the risk of
adverse pregnancy outcomes. We found, despite being at
similar latitudes, circulating 25(OH)D was different be-
tween women recruited in Adelaide compared to women
recruited in Auckland. This was independent of diet and
lifestyles factors including BMI and SEI and highlights
the difficulty in understanding the role of vitamin D in
pregnancy in human cohort studies. However, there was
a protective association of having high vitamin D at 15
± 1 weeks’ gestation and GDM once standardised based
on month serum was sampled. Furthermore, there may
be possible fetal sex specific differences in vitamin D sta-
tus worth considering in future studies.
Despite the similar latitudes of Adelaide and Auckland
(Adelaide: 34.93°S and Auckland 36.85°S), serum
25(OH)D was lower in the women recruited in Adelaide.
Given the significant number of characteristic and life-
style differences between the two populations, this is not
overly surprising. Previous studies have shown a positive
association between socioeconomic status and vitamin D
in both pregnant and non-pregnant women [36, 37].
The lower SEI of the Adelaide women could therefore
make them more susceptible to lower circulating
25(OH)D because of factors relating to disadvantage.
Furthermore, increased BMI is known to be associated
with reduced serum 25(OH)D [38–40] as adipose tissue
is thought to sequester 25(OH)D [41]. However, after
adjusting for factors shown to be associated with vitamin
D status including BMI and recreational walking, serum
25(OH)D remained significantly lower in the women
Fig. 1 Seasonal variation in serum 25(OH)D. a. Comparison of serum
25(OH)D levels based on month of sampling in the women
recruited in Adelaide (black line & left axis) and average hours of
sunlight per day in Adelaide (grey line & right axis). Seasonal
variation in vitamin D followed a similar pattern to hours of sunlight
although was slightly shifted. b. Seasonal variation of serum
25(OH)D based on month of sampling between women recruited in
Adelaide compared to Auckland. Data are mean ± SD
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recruited in Adelaide suggesting the influence of other fac-
tors not measured as part of SCOPE for example, hours
spent outside in the sun. As indicated by the seasonal vari-
ation in serum 25(OH)D, amongst women recruited in
Adelaide, vitamin D status declined significantly from Feb-
ruary to April whilst in the women recruited in Auckland,
serum 25(OH)D in March and April remained elevated
before declining.
Vitamin D deficiency has previously been associated
with insulin resistance and type 2 diabetes given its role
in supporting insulin secretion and pancreatic β-cell
function [42]. Furthermore, inverse relationships be-
tween serum 25(OH)D and both fasting glucose and
fasting insulin have been shown during pregnancy indi-
cating poorer glycaemic control [19, 43]. Therefore, the
protective role of high 25(OH)D 15 ± 1 weeks’ gestation
against GDM, as seen with a decreased risk of GDM in
women within the ‘high’ quartile of standardised vitamin
D compared to moderate-high, is consistent with know-
ledge about vitamin D and diabetes. This is also consist-
ent with another study that observed an increased risk
of GDM with vitamin D deficiency in early pregnancy
(aOR: 3.40; 95% CI: 2.03–4.98 [17]) and offers potential
physiological connections between vitamin D status and
the progression of insulin resistance in pregnant women.
Furthermore, studies have shown that vitamin D sup-
ports early placental development [44, 45] in which, ab-
normal placentation can be a characteristic of a number
of pregnancy complications including GDM, PE, sPTB
and SGA [46].
The placenta expresses all the necessary components
to convert 25(OH)D to the active form and thus utilise
active vitamin D either locally or in a paracrine manner
[45, 47]. Vitamin D metabolism in the placenta has been
shown to be influenced by testosterone production and
thus varies by fetal sex [35]. Furthermore, sex specific
differences in pregnancy outcome have also been re-
ported whereby the risk of sPTB, PE and GDM are all
higher in pregnancies with a male fetus [48–50]. In this
study, we observed marginal sex-specific differences be-
tween early pregnancy vitamin D status and pregnancy
outcome where by high vitamin D status and carrying a
male fetus was moderately associated with decreasing
the risk of having any pregnancy complication. Con-
versely, high vitamin D status and carrying a female fetus
was not associated with changing the risk of having any
pregnancy complication. Indeed, for the risk of GDM an
opposite effect of vitamin D status in early pregnancy
was observed depending on fetal sex. This is similar to
that which has previously been shown in the relationship
between vitamin D status at ≤26 weeks’ gestation and
placental pathology in pregnancy [51] suggesting that
male and female fetuses respond differently to maternal
vitamin D status.
Lack of statistically significant associations with other
pregnancy complications may reflect the fact that this was
a largely vitamin D-replete population (> 72% with serum
25(OH)D > 50 nmol/L) likely due to their residence latitude
as low serum 25(OH)D was found in the SCOPE Ireland
cohort [52]. Indeed many of the studies that have assessed
the association between vitamin D status and adverse preg-
nancy outcome that have reported statistically significant
differences have been in populations with higher rates of
vitamin D deficiency [2, 4]. High dose (> 2000 IU) vitamin
D supplementation is associated with decreasing risk of
pregnancy complications [23–25]. However, routine vita-
min D supplementation did not occur during the time
period the women in the current study were recruited. Fur-
thermore, multivitamin supplements available during the
study period contained very little (maximum 50 IU), if any,
vitamin D and thus are an unlikely source of variation
within the population. Inconsistencies in the literature may
also reflect other causative factors in which vitamin D is a
mediator. For example, active vitamin D (1,25-dihydroxyvi-
tamin D3) is the principal hormone that regulates calcium
absorption within the intestine [53] and is integral to main-
taining calcium homeostasis. During gestation, fetal de-
mand for calcium increases and it is imperative that
maternal vitamin D status remain adequate to support in-
creased calcium absorption from the gut [54]. Therefore,
vitamin D status may be important in populations where
dietary calcium intake is low which is unlikely in the popu-
lation of women studied here.
Conclusions
In conclusion, once standardised against month of sam-
pling, we demonstrate a protective effect of high vitamin D
with GDM. However, differences in vitamin D status be-
tween the women recruited in Adelaide and those recruited
in Auckland reflect obvious difficulties in studying how vita-
min D may support healthy pregnancies. A possible con-
nection between fetal sex, vitamin D status and pregnancy
complications reveals further questions and encourages
continual research and discussion into the role of vitamin D
in pregnancy, particularly in vitamin D replete populations.
Additional file
Additional file 1: Table S1. Adjusted relative risks (aRR) of pregnancy
complications from any complication, preeclampsia (PE), gestational
hypertension (GH), gestational diabetes mellitus (GDM), spontaeous
preterm birth (sPTB) and small-for-gestational age (SGA) according to
vitamin D status and stratified by fetal sex. (DOCX 15 kb)
Abbreviations
25(OH)D : 25-hydroxy vitamin D; aRR : adjusted risk ratio; BMI: body mass
index; CI: confidence interval; GDM: gestational diabetes mellitus;
GH: gestational hypertension; PE: preeclampsia; SCOPE: SCreening fOr
Pregnancy Endpoints; SEI: socioeconomic index; SGA: small for gestational
age; sPTB: spontaneous preterm birth
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